Exane Derivatives’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $148 | Sell |
5
-20
| -80% | -$592 | ﹤0.01% | 698 |
|
|
2022
Q1 | $703 | Hold |
25
| – | – | ﹤0.01% | 834 |
|
|
2021
Q4 | $1.15K | Hold |
25
| – | – | ﹤0.01% | 680 |
|
|
2021
Q3 | $820 | Sell |
25
-4,339
| -99% | -$142K | ﹤0.01% | 866 |
|
|
2021
Q2 | $147K | Buy |
4,364
+4,355
| +48,389% | +$146K | 0.03% | 475 |
|
|
2021
Q1 | $325 | Sell |
9
-158
| -95% | -$5.71K | ﹤0.01% | 817 |
|
|
2020
Q4 | $4.85K | Buy |
+167
| New | +$4.85K | ﹤0.01% | 546 |
|